Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study. [electronic resource]
Producer: 20180523Description: 2128-2134 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- Brain Neoplasms -- genetics
- Capecitabine -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- DNA Mismatch Repair -- genetics
- Disease-Free Survival
- Female
- Humans
- Male
- Middle Aged
- Mutation
- Neoplasm Metastasis
- Neoplastic Syndromes, Hereditary -- genetics
- Observation
- Proto-Oncogene Proteins B-raf -- genetics
- Treatment Outcome
- ras Proteins -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.